Search Results 721-730 of 18089 for multiple%20sclerosis
Synucleinopathies. Rochester, Minn. The goals of the study are to prospectively evaluate clinical and laboratory biomarkers of multiple system atrophy and ...
https://educationmedia.mayo.edu/media/Metabolic%20Associated%20Steatotoic%20Liver%20Disease%20%28MASLD%29%3A%20Biomarkers%2C%20Screening%20%26%20Treatment/ ...
Interim analysis of the ASPIRE clinical trial, which enrolled 792 patients with relapsed multiple myeloma from 20 countries, found an “unprecedented ...
... Multiple Myeloma or Lymphoma. The Phase 2 portion of the study will investigate the efficacy and safety of TAS4464 in patients with Multiple Myeloma or Lymphoma ...
The goals of the study are to prospectively evaluate clinical and laboratory biomarkers of multiple system atrophy and Parkinson's disease at early clinical ...
... multiple sclerosis (MS). Participants will be ... two fixed doses at two time points in patients with progressive diabetic kidney disease. ... 20 million cells. 20 ...
The purpose of this study is to develop a natural history dataset and biorepository of early Primary Lateral Sclerosis (PLS) and well-established PLS cases for ...
July 20, 2015. Share this: Share to facebook · Share ... two groups as the black circles are farthest from the purple and green circles. ... — Researchers on Mayo ...
Mayo Clinic cancer expert highlights advancements in treating multiple myeloma. Kelley Luckstein. March 20, 2023. Science Saturday: New standards and open ...
The purpose of this study is to target two ... Stiff Person Syndrome or Ataxia or Epilepsy with elevated anti-GAD serum antibody titers > 20 nM/L or CSF antibody ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.